{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:37:53Z","timestamp":1785267473509,"version":"3.55.0"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Diabetes mellitus (DM) is a group of metabolic diseases caused by absolute or relative deficiency of insulin secretion and characterized by chronic hyperglycemia. Its complications affect almost every tissue of the body, usually leading to blindness, renal failure, amputation, etc. and in the final stage, it mostly develops into cardiac failure, which is the main reason why diabetes mellitus manifests itself as a high clinical lethality. The pathogenesis of diabetes mellitus and its complications involves various pathological processes including excessive production of mitochondrial reactive oxygen species (ROS) and metabolic imbalance. Hypoxia-inducible Factor (HIF) signaling pathway plays an important role in both of the above processes. Roxadustat is an activator of Hypoxia-inducible Factor-1\u03b1, which increases the transcriptional activity of Hypoxia-inducible Factor-1\u03b1 by inhibiting hypoxia-inducible factor prolyl hydroxylase (HIF-PHD). Roxadustat showed regulatory effects on maintaining metabolic stability in the hypoxic state of the body by activating many downstream signaling pathways such as vascular endothelial growth factor (VEGF), glucose transporter protein-1 (GLUT1), lactate dehydrogenase (LDHA), etc. This review summarizes the current research findings of roxadustat on the diseases of cardiomyopathy, nephropathy, retinal damage and impaired wound healing, which also occur at different stages of diabetes and greatly contribute to the damage caused by diabetes to the organism. We attempts to uncover a more comprehensive picture of the therapeutic effects of roxadustat, and inform its expanding research about diabetic complications treatment.<\/jats:p>","DOI":"10.3389\/fphar.2023.1088288","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T07:11:59Z","timestamp":1676013119000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Roxadustat, a HIF-PHD inhibitor with exploitable potential on diabetes-related complications"],"prefix":"10.3389","volume":"14","author":[{"given":"Tingting","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1681\/ASN.2019060623","article-title":"Phase 3, randomized, double-blind, active-comparator (darbepoetin alfa) study of oral roxadustat in CKD patients with anemia on hemodialysis in Japan","volume":"31","author":"Akizawa","year":"","journal-title":"J. Am. Soc. Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/1744-9987.12888","article-title":"Intermittent oral dosing of roxadustat in peritoneal dialysis chronic kidney disease patients with anemia: A randomized, phase 3, multicenter, open-label study","volume":"24","author":"Akizawa","year":"","journal-title":"Ther. Apher. Dial."},{"key":"B3","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrneph.2014.177","article-title":"Diabetic nephropathy: HIF activation in prevention of diabetic nephropathy","volume":"10","author":"Allison","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/medicina54050073","article-title":"Association between the vicious cycle of diabetes-associated complications and glycemic control among the elderly: A systematic review","volume":"54","author":"Atif","year":"2018","journal-title":"Med. Kaunas."},{"key":"B5","doi-asserted-by":"publisher","first-page":"E473","DOI":"10.1152\/ajpendo.00467.2015","article-title":"Diabetic cardiomyopathy: Role of the E3 ubiquitin ligase","volume":"310","author":"Bai","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/cvr\/28.8.1176","article-title":"Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis","volume":"28","author":"Banai","year":"1994","journal-title":"Cardiovasc Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e000433","DOI":"10.1161\/JAHA.113.000433","article-title":"Taking diabetes to heart-deregulation of myocardial lipid metabolism in diabetic cardiomyopathy","volume":"2","author":"Bayeva","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/ndt\/gfv302","article-title":"Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients","volume":"30","author":"Besarab","year":"2015","journal-title":"Nephrol. Dial. Transpl."},{"key":"B9","doi-asserted-by":"publisher","first-page":"19426","DOI":"10.1073\/pnas.0805230105","article-title":"Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice","volume":"105","author":"Botusan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jdiacomp.2016.11.020","article-title":"Diabetic foot ulcer severity predicts mortality among veterans with type 2 diabetes","volume":"31","author":"Brennan","year":"2017","journal-title":"J. Diabetes Complicat."},{"key":"B11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/01.prs.0000293761.27219.84","article-title":"Pulsed electromagnetic fields accelerate normal and diabetic wound healing by increasing endogenous FGF-2 release","volume":"121","author":"Callaghan","year":"2008","journal-title":"Plast. Reconstr. Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","article-title":"Molecular pathogenesis of retinal and choroidal vascular diseases","volume":"49","author":"Campochiaro","year":"2015","journal-title":"Prog. Retin Eye Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bbalip.2005.03.005","article-title":"Fatty acid metabolism is enhanced in type 2 diabetic hearts","volume":"1734","author":"Carley","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"B14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00125-021-05380-z","article-title":"Hypoxia and hypoxia-inducible factors in diabetes and its complications","volume":"64","author":"Catrina","year":"2021","journal-title":"Diabetologia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"900","DOI":"10.2337\/dc13-1990","article-title":"Ocular anti-VEGF therapy for diabetic retinopathy: Overview of clinical efficacy and evolving applications","volume":"37","author":"Cheung","year":"2014","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1387\/ijdb.103214ec","article-title":"The role of angiogenic growth factors in organogenesis","volume":"55","author":"Crivellato","year":"2011","journal-title":"Int. J. Dev. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.3390\/biom11121894","article-title":"Bioactive antimicrobial peptides as therapeutic agents for infected diabetic foot ulcers","volume":"11","author":"Da Silva","year":"2021","journal-title":"Biomolecules"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1253\/circj.CJ-19-1039","article-title":"Roxadustat markedly reduces myocardial ischemia reperfusion injury in mice","volume":"84","author":"Deguchi","year":"2020","journal-title":"Circ. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40265-019-01077-1","article-title":"Roxadustat: First global approval","volume":"79","author":"Dhillon","year":"2019","journal-title":"Drugs"},{"key":"B22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000522584","article-title":"Therapeutic effect of extracellular vesicles derived from HIF prolyl hydroxylase domain enzyme inhibitor-treated cells on renal ischemia\/reperfusion injury","volume":"8","author":"Ding","year":"2022","journal-title":"Kidney Dis. (Basel)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jacbts.2018.04.005","article-title":"Fatty acids prevent hypoxia-inducible factor-1\u03b1 signaling through decreased succinate in diabetes","volume":"3","author":"Dodd","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.3390\/ijms20133264","article-title":"Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy","volume":"20","author":"Evangelista","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"R977","DOI":"10.1152\/ajpregu.00577.2003","article-title":"Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression","volume":"286","author":"Fandrey","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/978-3-319-75402-4_58","article-title":"VEGF as a trophic factor for m\u00fcller glia in hypoxic retinal diseases","volume":"1074","author":"Fu","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: Diagnosis, prevention, and treatment","volume":"28","author":"Gross","year":"2005","journal-title":"Diabetes Care"},{"key":"B29","doi-asserted-by":"publisher","first-page":"826","DOI":"10.7150\/ijbs.65938","article-title":"Neuraminidase 1 deficiency attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory via AMPK-SIRT3 pathway in diabetic cardiomyopathy mice","volume":"18","author":"Guo","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1152\/ajprenal.00174.2010","article-title":"Hypoxic regulation of erythropoiesis and iron metabolism","volume":"299","author":"Haase","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1749-6632.2009.05030.x","article-title":"Pathophysiological consequences of HIF activation: HIF as a modulator of fibrosis","volume":"1177","author":"Haase","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fcell.2020.00488","article-title":"Rank order of small molecule induced hypoxiamimesis to prevent retinopathy of prematurity","volume":"8","author":"Hoppe","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"E2516","DOI":"10.1073\/pnas.1523005113","article-title":"Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity","volume":"113","author":"Hoppe","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"118246","DOI":"10.1016\/j.lfs.2020.118246","article-title":"Hyperbaric oxygen potentiates diabetic wound healing by promoting fibroblast cell proliferation and endothelial cell angiogenesis","volume":"259","author":"Huang","year":"2020","journal-title":"Life Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1126\/science.aad9642","article-title":"Hypoxia as a therapy for mitochondrial disease","volume":"352","author":"Jain","year":"2016","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pharmthera.2017.09.003","article-title":"Hypoxia inducible factor as a therapeutic target for atherosclerosis","volume":"183","author":"Jain","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: A hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e12909","DOI":"10.1111\/cpr.12909","article-title":"HIF-1\u03b1 ameliorates tubular injury in diabetic nephropathy via HO-1-mediated control of mitochondrial dynamics","volume":"53","author":"Jiang","year":"2020","journal-title":"Cell Prolif."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1124\/mol.106.027029","article-title":"Hypoxia-inducible factor-1 (HIF-1)","volume":"70","author":"Ke","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e137557","DOI":"10.1172\/JCI137557","article-title":"HIF in the heart: Development, metabolism, ischemia, and atherosclerosis","volume":"131","author":"Knutson","year":"2021","journal-title":"J. Clin. Investigation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/ham.2018.0076","article-title":"The effects of high altitude on glucose homeostasis, metabolic control, and other diabetes-related parameters: From animal studies to real life","volume":"20","author":"Koufakis","year":"2019","journal-title":"High. Alt. Med. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.kint.2018.06.008","article-title":"HIF-1\u03b1 promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease","volume":"94","author":"Kraus","year":"2018","journal-title":"Kidney Int."},{"key":"B45","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1056\/NEJM200003023420904","article-title":"Early expression of angiogenesis factors in acute myocardial ischemia and infarction","volume":"342","author":"Lee","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1038\/s41467-021-23448-7","article-title":"A small molecule HIF-1\u03b1 stabilizer that accelerates diabetic wound healing","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"788977","DOI":"10.3389\/fphar.2021.788977","article-title":"Roxadustat (FG-4592) facilitates recovery from renal damage by ameliorating mitochondrial dysfunction induced by folic acid","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.7150\/thno.40735","article-title":"Distinct cardiac energy metabolism and oxidative stress adaptations between obese and non-obese type 2 diabetes mellitus","volume":"10","author":"Li","year":"","journal-title":"Theranostics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"6286984","DOI":"10.1155\/2020\/6286984","article-title":"Pretreatment with roxadustat (FG-4592) attenuates folic acid-induced kidney injury through antiferroptosis via akt\/GSK-3\u03b2\/nrf2 pathway","volume":"2020","author":"Li","year":"","journal-title":"Oxid. Med. Cell Longev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.7150\/thno.41839","article-title":"Bioactive antibacterial silica-based nanocomposites hydrogel scaffolds with high angiogenesis for promoting diabetic wound healing and skin repair","volume":"10","author":"Li","year":"","journal-title":"Theranostics"},{"key":"B51","doi-asserted-by":"publisher","first-page":"146154","DOI":"10.1155\/2012\/146154","article-title":"Inflammation in diabetic nephropathy","volume":"2012","author":"Lim","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1681\/ASN.2020111664","volume":"32","author":"Liu","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1167\/iovs.15-18066","article-title":"Prolyl-4-Hydroxylases inhibitor stabilizes HIF-1\u03b1 and increases mitophagy to reduce cell death after experimental retinal detachment","volume":"57","author":"Liu","year":"2016","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"104747","DOI":"10.1016\/j.phrs.2020.104747","article-title":"Roxadustat (FG-4592) treatment for anemia in dialysis-dependent (DD) and not dialysis-dependent (NDD) chronic kidney disease patients: A systematic review and meta-analysis","volume":"155","author":"Liu","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B55","first-page":"9161","article-title":"Survivin contributes to the progression of diabetic retinopathy through HIF-1\u03b1 pathway","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fphar.2020.01191","article-title":"Antianemia drug roxadustat (FG-4592) protects against doxorubicin-induced cardiotoxicity by targeting antiapoptotic and antioxidative pathways","volume":"11","author":"Long","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"130264","DOI":"10.1016\/j.bbagen.2022.130264","article-title":"Novel function of Roxadustat (FG-4592) as an anti-shock drug in sepsis by regulating mitochondrial oxidative stress and energy metabolism","volume":"1867","author":"Long","year":"2023","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"B58","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10557-021-07267-y","article-title":"\u03b2-Hydroxybutyrate exacerbates hypoxic injury by inhibiting HIF-1\u03b1-Dependent glycolysis in cardiomyocytes-adding fuel to the fire?","volume":"36","author":"Ma","year":"2021","journal-title":"Cardiovasc Drugs Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/MNH.0000000000000813","volume":"31","author":"Macdougall","year":"2022","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1113\/JP271242","article-title":"Increased oxidative metabolism following hypoxia in the type 2 diabetic heart, despite normal hypoxia signalling and metabolic adaptation","volume":"594","author":"Mansor","year":"2016","journal-title":"J. Physiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.2337\/diabetes.53.9.2383","article-title":"Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes","volume":"53","author":"Marfella","year":"2004","journal-title":"Diabetes"},{"key":"B62","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/0886022X.2021.1915801","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against renal ischemia\/reperfusion injury by inhibiting inflammation","volume":"43","author":"Miao","year":"2021","journal-title":"Ren. Fail"},{"key":"B63","doi-asserted-by":"publisher","first-page":"174583","DOI":"10.1016\/j.ejphar.2021.174583","article-title":"Hypoxia-inducible factor-prolyl hydroxylase inhibitors for renal anemia in chronic kidney disease: Advantages and disadvantages","volume":"912","author":"Mima","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrneph.2010.124","article-title":"The suffocating kidney: Tubulointerstitial hypoxia in end-stage renal disease","volume":"6","author":"Mimura","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrneph.2009.211","volume":"6","author":"Miyata","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/ki.2013.74","volume":"84","author":"Miyata","year":"2013","journal-title":"Kidney Int."},{"key":"B67","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.cmet.2013.04.001","article-title":"Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis","volume":"17","author":"Nagareddy","year":"2013","journal-title":"Cell Metab."},{"key":"B68","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/j.1440-1681.2006.04476.x","article-title":"Intrarenal oxygenation in chronic renal failure","volume":"33","author":"Norman","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1253\/circj.CJ-20-0233","volume":"84","author":"Ohashi","year":"2020","journal-title":"Circ. J."},{"key":"B70","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/CIRCRESAHA.114.300507","article-title":"Angiogenesis and cardiac hypertrophy: Maintenance of cardiac function and causative roles in heart failure","volume":"114","author":"Oka","year":"2014","journal-title":"Circ. Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.biochi.2022.01.001","volume":"202","author":"Patel","year":"2022","journal-title":"Biochimie"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/med.21883","article-title":"Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease","volume":"42","author":"Pereira","year":"2022","journal-title":"Med. Res. Rev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00125-012-2469-5","article-title":"Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db\/db mice as a model of type 2 diabetes","volume":"55","author":"Persson","year":"2012","journal-title":"Diabetologia"},{"key":"B74","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/dmrr.613","article-title":"Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction","volume":"22","author":"Piconi","year":"2006","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B75","first-page":"2408","article-title":"VEGF-initiated blood-retinal barrier breakdown in early diabetes","volume":"42","author":"Qaum","year":"2001","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4239\/wjd.v7.i13.271","article-title":"Preliminary study on overproduction of reactive oxygen species by neutrophils in diabetes mellitus","volume":"7","author":"Ridzuan","year":"2016","journal-title":"World J. Diabetes"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/path.2518","article-title":"Novel concepts in atherogenesis: Angiogenesis and hypoxia in atherosclerosis","volume":"218","author":"Sluimer","year":"2009","journal-title":"J. Pathol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.bbadis.2018.09.024","article-title":"Hypoxia-inducible factor 1 signalling, metabolism and its therapeutic potential in cardiovascular disease","volume":"1865","author":"Sousa Fialho","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1159\/000489652","article-title":"FG-4592 accelerates cutaneous wound healing by epidermal stem cell activation via HIF-1\u03b1 stabilization","volume":"46","author":"Tang","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4161\/cc.9.1.10371","article-title":"HIF-1alpha dysfunction in diabetes","volume":"9","author":"Thangarajah","year":"2010","journal-title":"Cell Cycle"},{"key":"B82","doi-asserted-by":"publisher","first-page":"13505","DOI":"10.1073\/pnas.0906670106","article-title":"The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues","volume":"106","author":"Thangarajah","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00017.2012","article-title":"Hypoxia and adipose tissue function and dysfunction in obesity","volume":"93","author":"Trayhurn","year":"2013","journal-title":"Physiol. Rev."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1681\/ASN.2005040393","article-title":"Linking metabolism and immunology: Diabetic nephropathy is an inflammatory disease","volume":"16","author":"Tuttle","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1159\/000453207","article-title":"Blocking mammalian target of rapamycin (mTOR) attenuates HIF-1\u03b1 pathways engaged-vascular endothelial growth factor (VEGF) in diabetic retinopathy","volume":"40","author":"Wei","year":"2016","journal-title":"Cell Physiol. Biochem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1055\/s-0042-100910","article-title":"Diabetes and cancer: A review of current knowledge","volume":"124","author":"Wojciechowska","year":"2016","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1042\/CS20210100","article-title":"Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability","volume":"135","author":"Wu","year":"2021","journal-title":"Clin. Sci. (Lond)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"109175","DOI":"10.1016\/j.biopha.2019.109175","article-title":"Salidroside and FG-4592 ameliorate high glucose-induced glomerular endothelial cells injury via HIF upregulation","volume":"118","author":"Xie","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B89","doi-asserted-by":"publisher","first-page":"gfac308","DOI":"10.1093\/ndt\/gfac308","article-title":"Roxadustat (FG-4592) protects against ischemia-induced acute kidney injury via improving CD73 and decreasing AIM2 inflammasome activation","author":"Yang","year":"2022","journal-title":"Nephrol. Dial. Transpl."},{"key":"B90","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1042\/CS20171625","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury","volume":"132","author":"Yang","year":"2018","journal-title":"Clin. Sci. (Lond)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e133690","DOI":"10.1172\/jci.insight.133690","article-title":"Roxadustat prevents Ang II hypertension by targeting angiotensin receptors and eNOS","volume":"6","author":"Yu","year":"2021","journal-title":"JCI Insight"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3892\/mmr.2020.11207","article-title":"Troxerutin attenuates oxygen\u2011glucose deprivation and reoxygenation\u2011induced oxidative stress and inflammation by enhancing the PI3K\/AKT\/HIF\u20111\u03b1 signaling pathway in H9C2 cardiomyocytes","volume":"22","author":"Yu","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"B93","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.26355\/eurrev_201808_15699","article-title":"Effects of HIF-1\u03b1 on diabetic retinopathy angiogenesis and VEGF expression","volume":"22","author":"Zhang","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/1440-1681.13601","article-title":"Roxadustat (FG-4592) protects against ischaemia\/reperfusion-induced acute kidney injury through inhibiting the mitochondrial damage pathway in mice","volume":"49","author":"Zhang","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000518172","article-title":"XCL1 aggravates diabetic nephropathy-mediated renal glomerular endothelial cell apoptosis and inflammatory response via regulating p53\/nuclear factor-kappa B pathway","volume":"146","author":"Zhang","year":"2022","journal-title":"Nephron"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e70714","DOI":"10.7554\/eLife.70714","article-title":"Repression of hypoxia-inducible factor-1 contributes to increased mitochondrial reactive oxygen species production in diabetes","volume":"11","author":"Zheng","year":"2022","journal-title":"Elife"},{"key":"B97","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"971795","DOI":"10.3389\/fphar.2022.971795","article-title":"Roxadustat: Not just for anemia","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/wrr.12708","article-title":"Roxadustat promotes angiogenesis through HIF-1\u03b1\/VEGF\/VEGFR2 signaling and accelerates cutaneous wound healing in diabetic rats","volume":"27","author":"Zhu","year":"2019","journal-title":"Wound Repair Regen."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1088288\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T07:12:03Z","timestamp":1676013123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1088288\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":99,"alternative-id":["10.3389\/fphar.2023.1088288"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1088288","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"article-number":"1088288"}}